Publications by authors named "Isabela N de Almeida"

Here, the antiviral activity of aminoadamantane derivatives were evaluated against SARS-CoV-2. The compounds exhibited low cytotoxicity to Vero, HEK293 and CALU-3 cells up to a concentration of 1,000 µM. The inhibitory concentration (IC) of aminoadamantane was 39.

View Article and Find Full Text PDF

The present observational study was designed to characterize the integrative profile of serum soluble mediators to describe the immunological networks associated with clinical findings and identify putative biomarkers for diagnosis and prognosis of active tuberculosis. The study population comprises 163 volunteers, including 84 patients with active pulmonary tuberculosis/(TB), and 79 controls/(C). Soluble mediators were measured by multiplexed assay.

View Article and Find Full Text PDF
Article Synopsis
  • Drug-resistant tuberculosis (DR-TB) is a significant public health challenge, with this study focused on evaluating various characteristics and outcomes related to DR-TB in Rio de Janeiro from 2016 to 2020.
  • Out of 148 DR-TB cases, a notable percentage exhibited different levels of drug resistance, with the majority being men under 44, largely from low-income backgrounds and having low educational attainment.
  • Factors like acquired resistance, positive sputum tests, and unemployment were linked to poorer treatment outcomes, underlining the urgent need for targeted public health policies to address DR-TB effectively.
View Article and Find Full Text PDF

Background: In last years, few attention has given to the patient's prediagnostic costs when evaluating the introduction of new technologies for tuberculosis (TB) and in this context, this study evaluated patient's costs and cost-effectiveness incurred with TB diagnosis comparing BactecMGIT960 system (MGIT) to the Löwestein-Jensen (LJ) culture in a health center and in a university hospital, in Rio de Janeiro City, Brazil.

Methods: Patient's mean costs were evaluated during the diagnosis process and cost-effectiveness based on mean time in days for the adoption of appropriate clinical anti-TB treatment in two health units comparing culture by means LJ and MGIT.

Results: The mean cost of LJ and MGIT in the health center was U.

View Article and Find Full Text PDF

Background: Heteroresistance is the coexistence of susceptible and resistant strains in the same individual, considered the preliminary step for total resistance, and can stem from mixed infection or clonal heterogeneity. The aim of this study was to evaluate the heteroresistance of Mycobacterium tuberculosis to rifampicin and isoniazid and its characterization.

Method: GenoType MTBDRplus; Sanger sequencing of the rpoB, katG, and inhA genes; and Mycobacterial Interspersed Repetitive Unit - Variable Number Tandem Repeat (MIRU-VNTR) were performed.

View Article and Find Full Text PDF

Background: Drug-resistant tuberculosis (TB) is an ongoing health threat, and the greatest challenge to adequate control of TB in many countries lies in the lack of proper laboratory drug-susceptibility test. The aim of this study was to evaluate the activity-based costs (ABC) of Kit SIRE Nitratase (Kit SIRE) and compare its values with the conventional drug-susceptibility test.

Methods: The ABC was calculated for three different approaches: Kit SIRE (clinical samples and cultures), proportion methods in Lowenstein Jensen (PM-LJ), and the Bactec™ MGIT™ 960 system based on Mycobacterial Research Laboratory's routine.

View Article and Find Full Text PDF

Background: Early diagnosis of tuberculosis (TB) and identification of strains of Mycobacterium tuberculosis resistant to anti-TB drugs are considered the main factors for disease control.

Objectives: To standardise a real-time polymerase chain reaction (qPCR) assay technique and apply it to identify mutations involved in M. tuberculosis resistance to Isoniazid (INH) directly in Ziehl-Neelsen (ZN) stained slides.

View Article and Find Full Text PDF

Background: The five BRICS (Brazil, Russian, Indian, China, and South Africa) countries bear 49% of the world's tuberculosis (TB) burden and they are committed to ending tuberculosis.

Objectives: The aim of this paper is to map the scientific landscape related to TB research in BRICS countries.

Methods: Were combined bibliometrics and social network analysis techniques to map the scientific publications related to TB produced by the BRICS.

View Article and Find Full Text PDF
Article Synopsis
  • TB-SPRINT is a microbead-based assay designed for rapid detection of tuberculosis and multidrug-resistant TB, aiming to improve clinic and research laboratory outcomes.
  • The study evaluated TB-SPRINT's performance against established systems, showing its accuracy in detecting rifampicin and isoniazid resistance ranged from 81% to 99%.
  • Despite promising results, further enhancements are necessary for TB-SPRINT to meet In Vitro Diagnostics standards, with costs calculated at approximately USD 127.78 for mean cost and USD 109.94 for activity-based costing.
View Article and Find Full Text PDF

Background: In recent decades, Mycobacterium tuberculosis with the RD genotype, frequently isolated from tuberculosis patients in Rio de Janeiro, has become part of the Latin American - Mediterranean (LAM) family and has been associated with multidrug-resistant tuberculosis (MDR-TB). The aim of this study was to investigate the frequency of M. tuberculosis RD in the state of Minas Gerais, Brazil, and its relationship with MDR-TB.

View Article and Find Full Text PDF

At a global level, with the increase in healthcare costs, there is a need to assess the economic impact of the incorporation of new technologies in different health disorders in different countries. There is scarce information regarding costs incurred with the use of current or new diagnostic tests for tuberculosis or from the vantage point of their incorporation within the healthcare systems of high-burden countries. The present study aimed to assess the mean cost and the activity based cost of the laboratory diagnosis for tuberculosis by means of conventional techniques and from the Detect TBLabTest molecular test kit in a general high-complexity hospital of the public health system in Brazil.

View Article and Find Full Text PDF

Background: We aimed to characterize the genetic diversity of drug-resistant Mycobacterium tuberculosis (MTb) clinical isolates and investigate the molecular epidemiology of multidrug-resistant (MDR) tuberculosis from Minas Gerais State, Brazil.

Methods: One hundred and four MTb clinical isolates were assessed by IS6110-RFLP, 24-locus mycobacterial interspersed repetitive units variable-number tandem repeats (MIRU-VNTR), TB-SPRINT (simultaneous spoligotyping and rifampicin-isoniazid drug-resistance mutation analysis) and 3R-SNP-typing (analysis of single-nucleotide polymorphisms in the genes involved in replication, recombination and repair functions).

Results: Fifty-seven different IS6110-RFLP patterns were found, among which 50 had unique patterns and 17 were grouped into seven clusters.

View Article and Find Full Text PDF

The possibility to obtain DNA from smears is a valuable alternative to remedy the lack of samples when they are totally used for bacilloscopy; this technique solves the biosafety problem related to a possible accident with the transportation of flasks containing potentially transmissible clinical samples. Hence, the purpose of this study was to utilize the insertion sequence IS6110 for amplification of DNA from a smear-positive sample for tuberculosis (TB) diagnosis. Among the 52 positive bacilloscopies, sensitivity, specificity, positive predictive value and negative predictive value were 52.

View Article and Find Full Text PDF

Background: Developments in molecular detection and strain differentiation of members of Mycobacterium tuberculosis complex have proved to be useful. The DNA extraction method influences the amplification efficiency, causing interference on the sensitivity and respective inhibitors. The aim of this study was to standardize a simple and fast DNA extraction method, providing DNA amplification by IS6110-PCR effectively free from undue interferences.

View Article and Find Full Text PDF